Finanzwire Finanzwire
Basculer en Français
10097 Companies
206690 Keywords
136846 Articles
109549 Press releases
Headlines Articles Press releases Dr. Jeffrey Lieberman Remove
  1. Home
  2. Companies
  3. Dr. Jeffrey Lieberman
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/21/2024 at 22:00, 2 years 1 month ago

    Dr. Jeffrey Lieberman sheds light on the mysteries of schizophrenia on "The People's Pharmacy" show

    Jeffrey A. Lieberman The People's Pharmacy Schizophrenia Early Treatment Mental Illness
  • PRESS RELEASE

    published on 02/21/2024 at 22:00, 2 years 1 month ago

    World-Leading Schizophrenia Expert Dr. Jeffrey A. Lieberman Unravels the Mysteries of Schizophrenia on The People’s Pharmacy

    Leading expert Dr. Jeffrey Lieberman discusses groundbreaking research on schizophrenia, early intervention, and prevention on The People's Pharmacy podcast
    Schizophrenia Dr. Jeffrey Lieberman Early Intervention Prevention The People's Pharmacy Podcast
    Logo of Dr. Jeffrey Lieberman
  • PRESS RELEASE

    published on 01/29/2024 at 17:00, 2 years 1 month ago

    Dr. Jeffrey Lieberman to Host "Mind-Bending Medicines" SXSW 2024 Meet Up

    Clinical neuroscientist Jeffrey A. Lieberman, M.D. will host a thought-provoking SXSW 2024 Meet Up to explore the therapeutic promises and potential perils of mind-bending medicines, including cannabis and psychedelics
    Jeffrey A. Lieberman SXSW 2024 Mind-bending Medicines Psychedelics Cannabis
    Logo of Dr. Jeffrey Lieberman
  • PRESS RELEASE

    published on 11/07/2023 at 06:00, 2 years 4 months ago

    Dr. Jeffery A. Lieberman, M.D., Best-Selling Author of Malady of the Mind, to Speak at the 2023 Miami Book Fair on Sunday, November 19th

    Logo of Dr. Jeffrey Lieberman
Accesswire
  • Published on 03/26/2026 at 11:07, 27 minutes ago

    U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    Pivotree Announces Fourth Quarter 2025 Results

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    Stagwell Expands the Harris Poll's Harrisquest Across Europe

  • Published on 03/26/2026 at 08:05, 3 hours 29 minutes ago

    Vanta Announces U.S. Ticker Symbol Change to VNTXF

  • Published on 03/26/2026 at 04:55, 6 hours 39 minutes ago

    Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 11:03, 31 minutes ago

    EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    Genel Energy PLC: Posting of Annual Report and Notice of AGM

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    Genel Energy PLC: Report on payments to governments for the year 2025

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026

  • Published on 03/26/2026 at 11:00, 34 minutes ago

    Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months

View all EQS
Les Echos
  • Published on 03/26/2026 at 08:57, 2 hours 36 minutes ago

    Edenred statement

  • Published on 03/26/2026 at 07:30, 4 hours 4 minutes ago

    BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

  • Published on 03/25/2026 at 18:53, 16 hours 40 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 17 hours 3 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 17:45, 17 hours 49 minutes ago

    Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy